Julie J. Olin, MD | Authors

MaxCare

Articles

Cognitive Function After Systemic Therapy for Breast Cancer

May 01, 2001

An underinvestigated area of breast cancer survivorship involves the possible impairment of cognitive function following adjuvant chemohormonal therapy. Numerous reports of disturbing and disruptive changes in short- and

New Strategies for Managing Metastatic Breast Cancer

May 01, 2000

In 1999, metastatic breast cancer claimed the lives of almost 45,000 women. For the vast majority of patients, metastatic breast cancer is an incurable disease with a median survival of only 2 to 3 years after diagnosis. The